|
|
|
|
Vol. 55, Issue 6, 957-969, June 1999
Department of Pharmacology, University of Pennsylvania School of
Medicine, Philadelphia, Pennsylvania (N.D.N., A.J.P., K.W.); and
Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan
(T.M., K.K., T.K., J.F., K.I.)
There are complex interactions between spermine, protons, and
ifenprodil at N-methyl-D-aspartate
receptors. Spermine stimulation may involve relief of proton
inhibition, whereas ifenprodil inhibition may involve an increase in
proton inhibition. We studied mutations at acidic residues in the NR1
subunit using voltage-clamp recording of NR1/NR2B receptors expressed
in Xenopus oocytes. Mutations at residues near the site
of the exon-5 insert, including E181 and E185, reduced spermine
stimulation and proton inhibition. Mutation NR1(D130N) reduced
sensitivity to ifenprodil by more than 500-fold, but had little effect
on sensitivity to spermine and pH. Mutations at six other residues in
this region of the NR1 subunit reduced the potency and, in some cases,
the maximum effect of ifenprodil. These mutants did not affect
sensitivity to pH, glutamate, glycine, or other hallmark properties of
N-methyl-D-aspartate channels such as
Mg2+ block and Ba2+ permeability. Residues in
this region presumably form part of the ifenprodil-binding site. To
model this region of NR1 we compared the predicted secondary structure
of NR1 (residues 19-400) with the known structures of 1,400 proteins.
This region of NR1 is most similar to bacterial
leucine/isoleucine/valine binding protein, a globular amino acid
binding protein containing two lobes, similar to the downstream S1-S2
region of glutamate receptors. We propose that the tertiary structure
of NR1(22-375) is similar to leucine/isoleucine/valine binding
protein, containing two "regulatory" domains, which we term R1 and
R2. This region, which contains the binding sites for spermine and
ifenprodil, may influence the downstream S1 and S2 domains that
constitute the glycine binding pocket.
This article has been cited by other articles:
![]() |
L. Mony, L. Krzaczkowski, M. Leonetti, A. Le Goff, K. Alarcon, J. Neyton, H.-O. Bertrand, F. Acher, and P. Paoletti Structural Basis of NR2B-Selective Antagonist Recognition by N-Methyl-D-aspartate Receptors Mol. Pharmacol., January 1, 2009; 75(1): 60 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, M. Miyazaki, S. Mizuno, M. Takigawa, T. Hirose, K. Nishimura, T. Toida, K. Williams, K. Kashiwagi, and K. Igarashi The Pore Region of N-Methyl-D-aspartate Receptors Differentially Influences Stimulation and Block by Spermine J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 68 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Erreger and S. F. Traynelis Zinc inhibition of rat NR1/NR2A N-methyl-D-aspartate receptors J. Physiol., February 1, 2008; 586(3): 763 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Villmann and C.-M. Becker On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor Neuroscientist, December 1, 2007; 13(6): 594 - 615. [Abstract] [PDF] |
||||
![]() |
B. H. Gabra, F. K. Kessler, J. K. Ritter, W. L. Dewey, and F. L. Smith Decrease in N-Methyl-D-aspartic Acid Receptor-NR2B Subunit Levels by Intrathecal Short-Hairpin RNA Blocks Group I Metabotropic Glutamate Receptor-Mediated Hyperalgesia J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 186 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, H. Sugiyama, M. Takigawa, D. Katagiri, H. Tomitori, K. Nishimura, N. Kaur, O. Phanstiel IV, M. Kitajima, H. Takayama, et al. Comparative Studies of Anthraquinone- and Anthracene-Tetraamines as Blockers of N-Methyl-D-aspartate Receptors J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, J. A. McRoberts, H. S. Ennes, M. Trevisani, P. Nicoletti, Y. Mittal, and E. A. Mayer Experimental colitis modulates the functional properties of NMDA receptors in dorsal root ganglia neurons Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G219 - G228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Scholz-Starke, A. Carpaneto, and F. Gambale On the Interaction of Neomycin with the Slow Vacuolar Channel of Arabidopsis thaliana J. Gen. Physiol., February 27, 2006; 127(3): 329 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Igarashi and K. Kashiwagi Polyamine Modulon in Escherichia coli: Genes Involved in the Stimulation of Cell Growth by Polyamines J. Biochem., January 1, 2006; 139(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishimura, R. Shiina, K. Kashiwagi, and K. Igarashi Decrease in Polyamines with Aging and Their Ingestion from Food and Drink J. Biochem., January 1, 2006; 139(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Low, P. Lyuboslavsky, A. French, P. Le, K. Wyatte, W. H. Thiel, E. M. Marchan, K. Igarashi, K. Kashiwagi, K. Gernert, et al. Molecular Determinants of Proton-Sensitive N-Methyl-D-aspartate Receptor Gating Mol. Pharmacol., June 1, 2003; 63(6): 1212 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Williams, M. Dattilo, T. N. Sabado, K. Kashiwagi, and K. Igarashi. Pharmacology of delta 2 Glutamate Receptors: Effects of Pentamidine and Protons J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mott, M. S. Washburn, S. Zhang, and R. J. Dingledine Subunit-Dependent Modulation of Kainate Receptors by Extracellular Protons and Polyamines J. Neurosci., February 15, 2003; 23(4): 1179 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pasternack, S. K. Coleman, A. Jouppila, D. G. Mottershead, M. Lindfors, M. Pasternack, and K. Keinanen alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Channels Lacking the N-terminal Domain J. Biol. Chem., December 13, 2002; 277(51): 49662 - 49667. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perin-Dureau, J. Rachline, J. Neyton, and P. Paoletti Mapping the Binding Site of the Neuroprotectant Ifenprodil on NMDA Receptors J. Neurosci., July 15, 2002; 22(14): 5955 - 5965. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kashiwagi, T. Masuko, C. D. Nguyen, T. Kuno, I. Tanaka, K. Igarashi, and K. Williams Channel Blockers Acting at N-Methyl-D-aspartate Receptors: Differential Effects of Mutations in the Vestibule and Ion Channel Pore Mol. Pharmacol., March 1, 2002; 61(3): 533 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Misra, S. G Brickley, M. Farrant, and S. G Cull-Candy Identification of subunits contributing to synaptic and extrasynaptic NMDA receptors in Golgi cells of the rat cerebellum J. Physiol., April 1, 2000; 524(1): 147 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Masuko, T. Kuno, K. Kashiwagi, T. Kusama, K. Williams, and K. Igarashi Stimulatory and Inhibitory Properties of Aminoglycoside Antibiotics at N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1026 - 1033. [Abstract] [Full Text] |
||||